Home »
NEWTON, Mass., Dec. 18, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial stage pharmaceutical company pioneering novel cancer therapies, today announced that the […] CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 3, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […] South San Francisco, CA — December 1, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the […] 20 November 2020 — AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, […] FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused […] NEW BRUNSWICK, N.J., November 14, 2020 – Johnson & Johnson (the Company) announced the expansion to the partnership between its Janssen Pharmaceutical Companies (Janssen) and the Biomedical Advanced Research […] INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network […] EAST HANOVER, N.J., Feb. 11, 2020 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) […] Generic prescription drugs have saved the U.S. about US$1.7 trillion over the past decade. The Food and Drug Administration approved a record 781 new generics […] About 10% of the world population suffers from migraine headaches, according to the National Institute of Neurological Disorders and Stroke. To alleviate migraine pain, people […] Researchers at the University of Alberta have discovered a new class of drugs with the potential to make cancer treatment safer and more effective by […] (HealthDay)—A cheap drug that’s been around for centuries as a gout treatment might also shield heart attack survivors from future heart crises, new trial results […] Survival for patients with the most common forms of advanced breast cancer could be substantially improved if both younger and older patients had access to […] Patients receiving checkpoint inhibitor therapy often have acute kidney injury (AKI), according to a study published online Oct. 31 in the Clinical Journal of the […] Prescriptions for drugs to treat anxiety, alcohol withdrawal and sleep problems are highest in the most deprived areas in England, according to a new study […] A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians at the University of California, Davis. A breath test […] In a new register-based study, Swedish and Danish researchers show that common drugs for Inflammatory Bowel Disease (IBD), so called TNF-α inhibitors, are not linked […] (HealthDay)—A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and […]
Karyopharm Announces FDA Approval of Xpovio (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate
Genentech Announces FDA Approval of Gavreto (pralsetinib) for People With Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers
Imfinzi Approved in the US for Less-Frequent, Fixed-Dose Use
FDA Approves Zokinvy
Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Novartis Announces MET Inhibitor Capmatinib (INC280), the First Potential Treatment for METex14 Mutated Advanced Non-Small Cell Lung Cancer, Granted Priority FDA Review
Why your generic drugs may not be safe and the FDA may be too lax
A new link between migraines, opioid overuse may be key to treating pain
Scientists discover new drugs with potential to treat stubborn cancers
Cheap, older gout drug could be a lifesaver after heart attack
Advanced breast cancer patients denied access to life-prolonging drugs and opioids
Acute kidney injury often seen with checkpoint inhibitor use
Prescribing rates for anxiety and sleeping drugs highest in deprived areas
A breath test for opioids
Study rejects link between common IBD drug and serious infections in children
FDA approves drug for most deadly form of tuberculosis
Copyright © 2021